An iRGD peptide conjugated heparin nanocarrier for gastric cancer therapy

The cis-diamminedichloroplatinum(ii) (DDP, cisplatin) is an important antitumor drug for the therapy of gastric cancer in clinics, but it is limited by its nonspecific tissue distribution and severe side effects. Here, an integrin targeted drug delivery system iRGD-heparin nanocarrier (iHP) was succ...

Descripción completa

Detalles Bibliográficos
Autores principales: Ai, Shichao, Zhen, Shuang, Liu, Zhijian, Sun, Feng, He, Xingchen, Chu, Feng, Guan, Wenxian, Wang, Jianquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2018
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085286/
https://www.ncbi.nlm.nih.gov/pubmed/35547284
http://dx.doi.org/10.1039/c8ra05071f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085286/
https://www.ncbi.nlm.nih.gov/pubmed/35547284
http://dx.doi.org/10.1039/c8ra05071f

Ejemplares similares